The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people

Hypertension

Volumn 33, Issue 5, 1999, Pages 1169-1174

  Tiret, Laurence ^c   Poirier, Odette ^d   Hallet, Vincent ^d   McDonagh, Theresa A ^d   Morrison, Caroline ^d   McMurray, John J V ^d   Dargie, Henry J ^d   Arveiler, Dominique ^a   Ruidavets, Jean Bernard ^a   Luc, Gérald ^a   Evans, Alun ^b   Cambien, François ^d  

^a MONICA Project   (France)

^b MONICA Project   (United Kingdom)

^c INSERM   (France)

^d NONE

Author keywords

Blood pressure; Body mass index; Endothelin; Genes; Hypertension, genetic; Myocardial infarction; Obesity

Indexed keywords

ENDOTHELIN 1;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HEART INFARCTION; HEREDITARY HYPERTENSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; TREADMILL EXERCISE;

EID: 0032895749     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.5.1169     Document Type: Article

References (44)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Simonson MS. Endothelins: multifunctional renal peptides. Physiol Rev. 1993;73:375-409.
3. Levin ER. Endothelins. N Engl J Med. 1995;333:356-363.
4. Lerman A, Edwards BS, Hallet JW, Heublein DM, Sandberg SM, Burnett JC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 1991;325:997-1001.
5. Winkles J, Alberts G, Brogi E, Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun. 1993;191:1081-1088.
6. Lerman A, Holmes DR, Bell MR, Garrat KR, Nishimura RA, Burnett JC. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 1995;92:2426-2431.
7. Zeiher AM, Ihling C, Pistorius K, Schachinger V, Schaefer HE. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndrome. Lancet. 1994;344:1405-1406.
8. Zeiher AM, Goebel H, Schachinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active atherosclerotic plaque: a clue to the mechanism of increased reactivity of the culprit lesion in unstable angina. Circulation. 1995;91:941-947.
9. Yasuda M, Kohno M, Tahara A, Itagane H, Toda I, Akioka K, Teragaki M, Oku H, Takeuchi K, Takeda T. Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J. 1990;119:801-806.
10. Stewart D, Kubac G, Costello K, Cernacek P. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol. 1991;18:38-43.
11. Ray S, McMurray J, Morton J, Dargie H. Circulating endothelin in acute ischaemic syndromes. Br Heart J. 1992;67:383-386.
12. Omland T, Lie R, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation. 1994;89:1573-1579.
13. Rodeheffer R, Lerman A, Heublein D, Burnett J. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc. 1992;67:719-724.
14. Wei C-M, Lerman A, Rodeheffer RJ, Mc Gregor CGA, Brandt RR, Scott W, Heublein DM, Kao PC, Edwards WD, Burnett JC. Endothelin in human congestive heart failure. Circulation. 1994;89:1580-1586.
15. Kiowski W, Sütsch G, Hunziker P, Müller P, Kim J, Oechslin J, Schmitt R, Jones R, Bertel O. Evidence for endothelin-1 mediated vasoconstriction in severe chronic heart failure. Lancet. 1995;346:732-736.
16. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sudishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature. 1996;384:353-355.
17. Lüscher T, Seo B, Bülher F. Potential role of endothelin in hypertension. Hypertension. 1993;21:752-757.
18. Vanhoutte P. Is endothelin involved in the pathogenesis of hypertension? Hypertension. 1993;21:747-751.
19. Schiffrin EL. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension. 1995;25:1135-1143.
20. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, Ogura M, Inoue A, Marumo F. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension. 1990;15:493-496.
21. Schiffrin E, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens. 1991;4:303-308.
22. Haak T, Jungmann E, Felber A, Hillmann U, Usadel K. Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens. 1992;5:161-166.
23. Lemne CE, Lundeberg T, Theodorsson E, De Faire U. Increased basal concentrations of plasma endothelin in borderline hypertension. J Hypertens. 1994;12:1069-1074.
24. Ergul S, Parish D, Puett D, Ergul A. Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension. Hypertension. 1996;28:652-655.
25. Schiffrin EL, Deng LY, Sventek P, Day R. Enhanced expression of endothelin-1 gene in resistance arteries in severe human hypertension. J Hypertens. 1997;15:57-63.
26. Hasegawa K, Fujiwara H, Doyama K, Inada T, Ohtani S, Fujiwara T, Hosoda K, Nakao K, Sasayama S. Endothelin-1 selective receptor in the arterial intima of patients with hypertension. Hypertension. 1994;23: 288-293.
27. Krum H, Viskoper R, Lacourciere Y, Budde M, Charlon V, for the Bosentan Hypertension Investigators. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. N Engl J Med. 1998;338:784-790.
28. Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste-Blazy P, Luc G, Richard JL, Ducimetière P, Cambien F. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: the ECTIM Study. Arterioscler Thromb. 1992;12:701-707.
29. MONICA Manual Part 3, Section 1: Population Survey Data Component Revision, March 1992. Geneva, Switzerland: World Health Organization; 1992.
30. McDonagh T, Morrison C, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray J. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997;350:829-833.
31. Hermann S, Ricard S, Nicaud V, Mallet C, Evans A, Ruidavets J, Arveiler D, Luc G, Cambien F. The P-selectin is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet. 1998;7:1277-1284.
32. Bloch K, Friedrich S, Lee M, Eddy R, Shows T, Quertermous T. Structural organization and chromosomal assignment of the gene encoding endothelin. J Biol Chem. 1989;264:10851-10857.
33. Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, Masaki T. The human preproendothelin-1 gene: complete nucleotide sequence and regulation of expression. J Biol Chem. 1989;264:14954-14959.
34. Stevens PA, Brown MJ. Genetic variability of the ET1 and ETA receptor genes in essential hypertension. J Cardiovasc Pharmacol. 1995;26:S9-S12.
35. Berge KE, Berg K. No effect of a Taq1 polymorphism in DNA at the endothelin 1 (EDN1) locus on normal blood pressure level or variability. Clin Genet. 1992;41:90-95.
36. Ferri C, Bellini C, Desideri G, Di Francesco L, Baldoncini R, Santucci A, De Mattia G. Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes. 1995;44:431-436.
37. Parrinello G, Scaglione R, Pinto A, Corrao S, Cecala M, Di Silvestre G, Amato P. Licata A, Licata G. Central obesity and hypertension: the role of plasma endothelin. Am J Hypertens. 1996;9:1186-1191.
38. Wolpert H, Steen S, Istfan N, Simonson D. Insulin modulates circulating endothelin-1 levels in humans. Metabolism. 1993;42:1027-1030.
39. Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone M, Bellini C, Properzi G, Valesini G, De Mattia G, Santucci A. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab. 1995;80:829-835.
40. Maeda S, Miyauchi T, Goto K, Matsuda M. Alteration of plasma endothelin-1 by exercise at intensities lower and higher than ventilatory threshold. J Appl Physiol. 1994;77:1399-1402.
41. Maxwell M, Heber D, Waks A, Tuck M. Role of insulin and norepinephrine in the hypertension of obesity. Am J Hypertens. 1994;7: 402-408.
42. Grassi G, Seravalle G, Cattaneo B, Bolla G, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G. Sympathetic activation in obese normotensive subjects. Hypertension. 1995;25: 560-563.
43. Pratley R, Coon P, Rogus E, Goldberg A. Effects of weight loss on norepinephrine and insulin levels in obese older men. Metabolism. 1995; 44:438-444.
44. Maeda S, Miyauchi T, Sakane M, Saito M, Maki S, Goto K, Matsuda M. Does endothelin-1 participate in the exercise-induced changes of blood flow distribution of muscles in humans? J Appl Physiol. 1997;82: 1107-1111.